Trident Lifeline Limited (BOM:543616)
India · Delayed Price · Currency is INR 413.75
-8.75 (-2.07%)
At close: Nov 6, 2026
Trident Lifeline Revenue
Trident Lifeline had revenue of 470.84M INR in the quarter ending September 30, 2026, with 50.25% growth. This brings the company's total for the last twelve months to 1.60B, up 44.24% year-over-year. In the fiscal year ending March 31, 2026, Trident Lifeline had annual revenue of 1.29B with 48.36% growth. That makes Trident Lifeline the 34,750th largest company in the world by revenue and 2,780th in India.
Revenue (ttm)
1.60B
Revenue Growth
+44.24%
P/S Ratio
3.08
Revenue / Employee
34.83M
Employees
46
Market Cap
4.94B
Revenue by Geography
- India 763.07M 59.1%
- Ghana 158.98M 12.3%
- Peru 129.37M 10.0%
- Rest of World 105.99M 8.2%
- Kenya 85.87M 6.7%
- Venezuela 46.95M 3.6%
Fiscal year ended Mar 31, 2026 See the full Trident Lifeline breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.29B | 420.57M | 48.36% |
| Mar 31, 2025 | 869.65M | 423.36M | 94.86% |
| Mar 31, 2024 | 446.29M | 129.36M | 40.82% |
| Mar 31, 2023 | 316.92M | 99.24M | 45.59% |
| Mar 31, 2022 | 217.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sudarshan Pharma Industries | 7.80B |
| Anuh Pharma | 7.78B |
| Wanbury | 6.53B |
| ZIM Laboratories | 3.97B |
| Albert David | 3.64B |
| Kilitch Drugs (India) | 2.37B |
| Medicamen Biotech | 2.06B |
| Ambalal Sarabhai Enterprises | 2.06B |